Literature DB >> 20104187

Serum fragmented cytokeratin 18 levels reflect the histologic activity score of nonalcoholic fatty liver disease more accurately than serum alanine aminotransferase levels.

Masaru Tsutsui1, Naoki Tanaka, Masatomo Kawakubo, Yo Sheena, Akira Horiuchi, Michiharu Komatsu, Tadanobu Nagaya, Satoru Joshita, Takeji Umemura, Tetsuya Ichijo, Akihiro Matsumoto, Kaname Yoshizawa, Toshifumi Aoyama, Eiji Tanaka, Kenji Sano.   

Abstract

BACKGROUND AND GOALS: Reliable noninvasive biomarkers to assess the histologic activity of nonalcoholic fatty liver disease (NAFLD) have not been established. As the frequency of Mallory bodies is known to be closely associated with the disease severity, we hypothesized that serum levels of Mallory body-related proteins were correlated with NAFLD histologic activity and evaluated this possibility. STUDY: Serum levels of total and fragmented cytokeratin (CK) 18, heat shock protein (Hsp) 70, Hsp90alpha, ubiquitin+1, and p38alpha at the time of liver biopsy were measured in 118 NAFLD patients and their association with histologic findings and NAFLD histologic activity score (NAS) was investigated.
RESULTS: Serum levels of both forms of CK18 and Hsp90alpha were markedly higher in patients having nonalcoholic steatohepatitis (NASH) compared with non-NASH ones. Both forms of CK18 significantly correlated with degree of steatosis, lobular inflammation, and ballooning, and showed stronger positive correlations with NAS than serum aspartate and alanine aminotransferase (AST and ALT). Multiple regression analysis further revealed that fragmented CK18 and AST were effective predictors of NAS, with the former being the more definitive of the two (P<0.001 vs. 0.005). In 20 NAFLD patients who received a follow-up biopsy, changes in fragmented CK18 levels, but not AST or ALT levels, closely paralleled those in NAS.
CONCLUSIONS: These results establish the usefulness of fragmented CK18 measurement for assessing and monitoring the histologic activity of NAFLD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20104187     DOI: 10.1097/MCG.0b013e3181bdefe2

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  35 in total

1.  Clinical characteristics of young-onset ischemic colitis.

Authors:  Takefumi Kimura; Akihiro Shinji; Akira Horiuchi; Naoki Tanaka; Tadanobu Nagaya; Takashi Shigeno; Naoshi Nakamura; Michiharu Komatsu; Takeji Umemura; Norikazu Arakura; Akihiro Matsumoto; Eiji Tanaka
Journal:  Dig Dis Sci       Date:  2012-03-01       Impact factor: 3.199

2.  Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease.

Authors:  Raj Vuppalanchi; Ajay K Jain; Ross Deppe; Katherine Yates; Megan Comerford; Howard C Masuoka; Brent A Neuschwander-Tetri; Rohit Loomba; Elizabeth M Brunt; David E Kleiner; Jean P Molleston; Jeffrey B Schwimmer; Joel E Lavine; James Tonascia; Naga Chalasani
Journal:  Clin Gastroenterol Hepatol       Date:  2014-05-17       Impact factor: 11.382

3.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

4.  Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan.

Authors:  Yoshio Sumida; Yuichiro Eguchi; Masafumi Ono
Journal:  World J Hepatol       Date:  2010-10-27

Review 5.  Keratins: Biomarkers and modulators of apoptotic and necrotic cell death in the liver.

Authors:  Nam-On Ku; Pavel Strnad; Heike Bantel; M Bishr Omary
Journal:  Hepatology       Date:  2016-04-04       Impact factor: 17.425

6.  Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.

Authors:  Yuta Aida; Hiroshi Abe; Yoichi Tomita; Tomohisa Nagano; Nobuyoshi Seki; Tomonori Sugita; Munenori Itagaki; Haruya Ishiguro; Satoshi Sutoh; Yoshio Aizawa
Journal:  Int J Clin Exp Med       Date:  2014-11-15

7.  Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.

Authors:  Bryan D Maliken; James E Nelson; Heather M Klintworth; Mary Beauchamp; Matthew M Yeh; Kris V Kowdley
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

Review 8.  Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

Authors:  Neven Baršić; Ivan Lerotić; Lea Smirčić-Duvnjak; Vedran Tomašić; Marko Duvnjak
Journal:  World J Gastroenterol       Date:  2012-08-14       Impact factor: 5.742

Review 9.  Alcoholic and non-alcoholic steatohepatitis.

Authors:  Manuela G Neuman; Samuel W French; Barbara A French; Helmut K Seitz; Lawrence B Cohen; Sebastian Mueller; Natalia A Osna; Kusum K Kharbanda; Devanshi Seth; Abraham Bautista; Kyle J Thompson; Iain H McKillop; Irina A Kirpich; Craig J McClain; Ramon Bataller; Radu M Nanau; Mihai Voiculescu; Mihai Opris; Hong Shen; Brittany Tillman; Jun Li; Hui Liu; Paul G Thomes; Murali Ganesan; Steve Malnick
Journal:  Exp Mol Pathol       Date:  2014-09-11       Impact factor: 3.362

Review 10.  Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer.

Authors:  Abigale Lade; Luke A Noon; Scott L Friedman
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.